DMK PHARMACEUTICALS CORPORATION Deferred Revenue (Non-Current)
DMK PHARMACEUTICALS CORPORATION had Deferred Revenue (Non-Current) of $157.41 thousand as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2023-11-14
- 2023-09-30: Deferred Revenue, Noncurrent $157.41K.
- 2023-06-30: Deferred Revenue, Noncurrent $164.36K.
- 2023-03-31: Deferred Revenue, Noncurrent $171.30K.
- 2022-12-31: Deferred Revenue, Noncurrent $178.25K.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2023-09-30 | $157.41K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $164.36K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $171.30K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $178.25K 10-Q · filed 2023-11-14 |
| 2022-09-30 | $185.19K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $700.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $725.00K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $750.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $775.00K 10-Q · filed 2021-11-22 |
| 2021-06-30 | $800.00K 10-Q · filed 2021-11-22 |
| 2021-03-31 | $825.00K 10-Q · filed 2021-11-22 |
| 2020-12-31 | $850.00K 10-K · filed 2022-03-31 |
| 2020-09-30 | $875.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $900.00K 10-Q · filed 2020-08-17 |
| 2019-12-31 | $800.00K 10-K · filed 2021-04-15 |